Capstead Mortgage Corp (CMO)

6.5  +0.16 (+2.52%)

After market: 6.55 +0.05 (+0.77%)

Fundamental Rating

1

Taking everything into account, CMO scores 1 out of 10 in our fundamental rating. CMO was compared to 64 industry peers in the Mortgage Real Estate Investment Trusts (REITs)" industry. CMO has a bad profitability rating. Also its financial health evaluation is rather negative. CMO has a expensive valuation and it also scores bad on growth.



0

1. Profitability

1.1 Basic Checks

CMO had positive earnings in the past year.

1.2 Ratios

Industry RankSector Rank
ROA 1.11%
ROE 9.95%
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

Industry RankSector Rank
OM 89.2%
PM (TTM) 74.91%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A

0

2. Health

2.1 Basic Checks

CMO has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.

2.2 Solvency

A Debt/Equity ratio of 7.91 is on the high side and indicates that CMO has dependencies on debt financing.
Industry RankSector Rank
Debt/Equity 7.91
Debt/FCF N/A
Altman-Z N/A
ROIC/WACCN/A
WACCN/A

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A

1

3. Growth

3.1 Past

The earnings per share for CMO have decreased strongly by -11.67% in the last year.
The Earnings Per Share has been decreasing by -7.88% on average over the past years.
CMO shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -57.19%.
CMO shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -2.90% yearly.
EPS 1Y (TTM)-11.67%
EPS 3Y0.52%
EPS 5Y-7.88%
EPS growth Q2Q-50%
Revenue 1Y (TTM)-57.19%
Revenue growth 3Y-7.17%
Revenue growth 5Y-2.9%
Revenue growth Q2Q-56.83%

3.2 Future

Based on estimates for the next years, CMO will show a small growth in Earnings Per Share. The EPS will grow by 1.36% on average per year.
The Revenue is expected to decrease by -7.18% on average over the next years.
EPS Next Y-2.11%
EPS Next 2Y3.92%
EPS Next 3Y0.84%
EPS Next 5Y1.36%
Revenue Next Year-39.38%
Revenue Next 2Y-19.44%
Revenue Next 3Y-13.42%
Revenue Next 5Y-7.18%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.

2

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 12.26 indicates a correct valuation of CMO.
When comparing the Price/Earnings ratio of CMO to the average of the S&P500 Index (24.92), we can say CMO is valued rather cheaply.
Based on the Price/Forward Earnings ratio of 9.26, the valuation of CMO can be described as reasonable.
CMO's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 21.49.
Industry RankSector Rank
PE 12.26
Fwd PE 9.26

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA 38.02

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y3.92%
EPS Next 3Y0.84%

1

5. Dividend

5.1 Amount

With a yearly dividend of 0.77%, CMO is not a good candidate for dividend investing.
Compared to an average S&P500 Dividend Yield of 2.41, CMO's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 0.77%

5.2 History

The dividend of CMO decreases each year by -40.61%.
CMO has been paying a dividend for over 5 years, so it has already some track record.
Dividend Growth(5Y)-40.61%
Div Incr YearsN/A
Div Non Decr YearsN/A

5.3 Sustainability

CMO pays out 88.97% of its income as dividend. This is not a sustainable payout ratio.
DP88.97%
EPS Next 2Y3.92%
EPS Next 3Y0.84%

Capstead Mortgage Corp

NYSE:CMO (10/18/2021, 7:43:55 PM)

After market: 6.55 +0.05 (+0.77%)

6.5

+0.16 (+2.52%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryMortgage Real Estate Investment Trusts (REITs)"
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap629.69M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield 0.77%
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE 12.26
Fwd PE 9.26
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 1.11%
ROE 9.95%
ROCE
ROIC
ROICexc
ROICexgc
OM 89.2%
PM (TTM) 74.91%
GM N/A
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.01
Health
Industry RankSector Rank
Debt/Equity 7.91
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio N/A
Quick Ratio N/A
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)-11.67%
EPS 3Y0.52%
EPS 5Y
EPS growth Q2Q
EPS Next Y-2.11%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-57.19%
Revenue growth 3Y-7.17%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y